Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human T-lymphotropic Virus 1”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableStudy completedNCT02877030
What this trial is testing

Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus

Who this might be right for
HTLV-1
Pedreira, Érika, M.D. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06698003
What this trial is testing

Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Who this might be right for
T-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more
Memorial Sloan Kettering Cancer Center 134
Testing effectiveness (Phase 2)Ended earlyNCT00117845
What this trial is testing

Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Who this might be right for
Leukemia, Adult T-Cell
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT01274533
What this trial is testing

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

Who this might be right for
Adult T Cell Leukemia/Lymphoma
Columbia University 4
Testing effectiveness (Phase 2)WithdrawnNCT01620736
What this trial is testing

Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

Who this might be right for
Human T-cell Leukemia Virus Type 1 Infection
Washington University School of Medicine
Early research (Phase 1)Looking for participantsNCT04301076
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Not applicableStudy completedNCT01149837
What this trial is testing

Evaluation of InnoLIA HTLV I/II Score

Who this might be right for
Human T-Lymphotrophic Virus Type I and/or Type II
Creative Testing Solutions 3,305
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Not applicableStudy completedNCT04830319
What this trial is testing

Pilates Method in People With HAM/TSP

Who this might be right for
HAM/TSPHTLV-1 Secondary MyelopathyBalance+2 more
Pedreira, Érika, M.D. 22
Testing effectiveness (Phase 2)Study completedNCT00041327
What this trial is testing

Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium 19
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Ended earlyNCT00823641
What this trial is testing

The HAM Infliximab Study

Who this might be right for
HTLV-I-associated Myelopathy
Imperial College London 3
Post-approval studies (Phase 4)Ended earlyNCT00854581
What this trial is testing

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Who this might be right for
LymphomaPrecancerous/Nonmalignant Condition
University of Miami 13
Early research (Phase 1)Study completedNCT05240612
What this trial is testing

A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Who this might be right for
HTLV-1-Associated Myelopathy (HAM)
Tanabe Pharma Corporation 15
Not applicableStudy completedNCT00001156
What this trial is testing

Assessment of Patients With Multiple Sclerosis (MS)

Who this might be right for
Herpesviridae InfectionHTLV-I InfectionMultiple Sclerosis+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 1,388
Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Not applicableStudy completedNCT01754311
What this trial is testing

Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1

Who this might be right for
HTLV-I Infections
University Hospital Center of Martinique 155
Not applicableStudy completedNCT01651819
What this trial is testing

Urological Physical Therapy in HTLV-1 With Urinary Symptoms

Who this might be right for
Tropical Spastic ParaparesisHTLV-1
Hospital Universitário Professor Edgard Santos 20
Not applicableStudy completedNCT00001582
What this trial is testing

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

Who this might be right for
T-cell LymphomaB-Cell LymphomaATL+1 more
National Cancer Institute (NCI) 902
Next Page